XSHE300111
Market cap537mUSD
Jan 10, Last price
3.06CNY
1D
-2.55%
1Q
7.75%
Jan 2017
-41.94%
IPO
-74.57%
Name
Zhejiang Sunflower Great Health LLC
Chart & Performance
Profile
Zhejiang Sunflower Great Health Limited Liability Company engages in the research, development, production, and sale of solar energy batteries and components worldwide. It offers polycrystalline silicon wafers; and photovoltaic cells and modules. The company was formerly known as Zhejiang Sunflower Light Energy Science & Technology Limited Liability Company and changed its name to Zhejiang Sunflower Great Health Limited Liability Company in March 2020. Zhejiang Sunflower Great Health Limited Liability Company was founded in 2005 and is headquartered in Shaoxing, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 338,419 0.76% | 335,859 12.97% | |||||||
Cost of revenue | 332,633 | 311,503 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 5,786 | 24,356 | |||||||
NOPBT Margin | 1.71% | 7.25% | |||||||
Operating Taxes | 990 | 71 | |||||||
Tax Rate | 17.11% | 0.29% | |||||||
NOPAT | 4,796 | 24,285 | |||||||
Net income | 21,748 | ||||||||
Dividends | (1,658) | ||||||||
Dividend yield | 0.04% | ||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 45,723 | 31,313 | |||||||
Long-term debt | 1,747 | 3,576 | |||||||
Deferred revenue | 596 | 1,106 | |||||||
Other long-term liabilities | 36,678 | 36,505 | |||||||
Net debt | (832,743) | (200,011) | |||||||
Cash flow | |||||||||
Cash from operating activities | 2,870 | 24,158 | |||||||
CAPEX | (10,295) | ||||||||
Cash from investing activities | (13,246) | ||||||||
Cash from financing activities | 634,497 | 28,445 | |||||||
FCF | 102,124 | 77,619 | |||||||
Balance | |||||||||
Cash | 879,149 | 233,191 | |||||||
Long term investments | 1,064 | 1,709 | |||||||
Excess cash | 863,292 | 218,107 | |||||||
Stockholders' equity | 198,630 | 1,343,337 | |||||||
Invested Capital | 694,769 | 261,316 | |||||||
ROIC | 1.00% | 9.00% | |||||||
ROCE | 0.65% | 5.08% | |||||||
EV | |||||||||
Common stock shares outstanding | 1,279,286 | 1,119,800 | |||||||
Price | 3.04 -6.75% | 3.26 3.49% | |||||||
Market cap | 3,889,029 6.53% | 3,650,548 3.49% | |||||||
EV | 3,187,490 | 3,579,581 | |||||||
EBITDA | 24,208 | 40,850 | |||||||
EV/EBITDA | 131.67 | 87.63 | |||||||
Interest | 5,336 | 442 | |||||||
Interest/NOPBT | 92.22% | 1.81% |